000788.SHE PKU HealthCare Corp Ltd
- Market cap
- CNY 3.16B
- P/E
- 132.8x
- P/B
- 1.97x
- ROE
- 6.5%
- Dividend yield
- 1.16%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 000788.SHE undervalued?
Graham numberThe Graham number of PKU HealthCare Corp Ltd cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
PKU HealthCare Corp Ltd fundamental analysis
No fundamental analysis for PKU HealthCare Corp Ltd yet.
PKU HealthCare Corp Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About PKU HealthCare Corp Ltd
PKU HealthCare Corp.,Ltd. engages in the research, development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China. The company offers anti-infectives, analgesics, psychotropic drugs, digestive system drugs, and cardiovascular drugs; procurement and pharmacy outsourcing; and cancer screening, health management, and treatment services related to healthcare management and care delivery, as well as involved i…
Full company profilePKU HealthCare Corp Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
PKU HealthCare Corp Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.07B | 2.15B | 2.32B | 2.51B | 1.98B | 2.24B | 2.08B | 2.19B | 2.06B | 1.48B | 870M |
| Gross Profit | 400M | 566M | 807M | 953M | 884M | 909M | 772M | 712M | 548M | 416M | 297M |
| Operating Income | 28.8M | 40.0M | 64.6M | 73.4M | 55.5M | 61.9M | 71.5M | 78.4M | 172M | 158M | 125M |
| EBITDA | 77.0M | 64.0M | 92.8M | 96.1M | 88.0M | 106M | 115M | 110M | 206M | 159M | 121M |
| Net Income | 12.6M | 34.3M | 45.2M | 50.2M | 39.2M | 43.1M | 55.6M | 44.4M | 138M | 82.9M | 98.4M |
| EPS | 0.02 | 0.06 | 0.08 | 0.08 | 0.07 | 0.07 | 0.09 | 0.07 | 0.23 | 0.14 | 0.17 |
| Balance Sheet | |||||||||||
| Total Assets | 2.04B | 2.08B | 2.14B | 2.46B | 2.31B | 2.54B | 2.64B | 2.44B | 2.29B | 1.99B | 1.95B |
| Total Liabilities | 903M | 905M | 934M | 1.21B | 1.01B | 1.21B | 1.26B | 1.02B | 776M | 432M | 431M |
| Shareholders' Equity | 1.14B | 1.18B | 1.21B | 1.25B | 1.30B | 1.34B | 1.38B | 1.42B | 1.51B | 1.56B | 1.52B |
| Cash & Short-term Investments | 491M | 420M | 521M | 669M | 477M | 446M | 634M | 457M | 617M | 909M | 842M |
| Total Debt | 167M | 155M | 130M | 313M | 342M | 354M | 170M | 82.1M | 40.8M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -117M | -26.3M | 204M | -5.78M | -68.1M | 59.1M | 279M | 122M | 348M | 387M | - |
| Capital Expenditure | 22.6M | 11.1M | 37.1M | 41.4M | 58.1M | 45.4M | 35.3M | 63.2M | 39.4M | 48.8M | 11.3M |
| Free Cash Flow | -139M | -37.4M | 167M | -47.2M | -126M | 13.7M | 244M | 58.6M | 308M | 339M | 424M |
| Ratios | |||||||||||
| ROE | 1.1% | 2.9% | 3.7% | 4.0% | 3.0% | 3.2% | 4.0% | 3.1% | 9.1% | 5.3% | 6.5% |
| ROA | 0.6% | 1.7% | 2.1% | 2.0% | 1.7% | 1.7% | 2.1% | 1.8% | 6.0% | 4.2% | 5.0% |
| Net Profit Margin | 0.6% | 1.6% | 2.0% | 2.0% | 2.0% | 1.9% | 2.7% | 2.0% | 6.7% | 5.6% | 11.3% |
| Debt to Equity | 0.15x | 0.13x | 0.11x | 0.25x | 0.26x | 0.26x | 0.12x | 0.06x | 0.03x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
PKU HealthCare Corp Ltd dividends
- Dividend yield
- 1.16%
- Forward dividend
- 0.17 CNY
- Payout ratio
- 44.1%
- Ex-dividend date
- Nov 3, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 36.6M | 0.06 | 44.1% |
| 2024 | CNY 46.5M | 0.08 | 33.7% |
| 2023 | CNY 3.87M | 0.01 | 8.7% |
| 2022 | CNY 27.6M | 0.05 | 49.6% |
| 2021 | CNY 19.3M | 0.03 | 44.8% |
| 2020 | CNY 13.5M | 0.02 | 34.5% |
| 2019 | CNY 11.9M | 0.02 | 23.7% |
| 2018 | CNY 18.5M | 0.03 | 41.0% |
| 2017 | CNY 8.25M | 0.01 | 24.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 14:10 on Mar 18, 2011.
Who owns PKU HealthCare Corp Ltd
- Insiders 32.01%
- Institutions 0.46%
- Public & others 67.53%
- Shares outstanding 596M
- Free float 424M
PKU HealthCare Corp Ltd company profile
- Company name
- PKU HealthCare Corp Ltd
- Ticker
- 000788.SHE
- ISIN
- CNE0000008M0
- Exchange
- Shenzhen Stock Exchange
- Listed since
- May 27, 1997
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 789
- Fiscal year end
- December
- Address
- Palm Springs International Center, Chongqing, China, 401121
- Phone
- 86 23 6301 4398
- Website
- pku-hc.com
About PKU HealthCare Corp Ltd
PKU HealthCare Corp.,Ltd. engages in the research, development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China. The company offers anti-infectives, analgesics, psychotropic drugs, digestive system drugs, and cardiovascular drugs; procurement and pharmacy outsourcing; and cancer screening, health management, and treatment services related to healthcare management and care delivery, as well as involved in distribution, retail, and hospital sales of pharmaceuticals, medical devices, and consumables. It also provides ceftriaxone sodium, meropenem, and cefminox sodium for injection; moxifloxacin hydrochloride injection; clindamycin palmitate hydrochloride granules; naphazoline capsules; celecoxib capsules; dextroketoneprofen tablets and capsules; buspirone hydrochloride tablets; and olanzapine tablets. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare Corp., Ltd. in November 2013. PKU HealthCare Corp.,Ltd. was founded in 1993 and is headquartered in Chongqing, China.
PKU HealthCare Corp Ltd management
6- Mr. Xiren XuNon-Independent Chairman & President · born 1979
- Mr. Quan Bo ZhaoVP & CFO · born 1972
- Mr. Yu Fei YuanSecretary of the Board · born 1972
- Mr. Qing Kai HeVice President · born 1971
- Mr. Mengchuan YuVice President · born 1964
- Liao CuiAccounting Supervisor